CLINICAL SIGNIFICANCE OF THE VEGFR-2 IN THE TUMORS AND BLOOD SERA OF THE BREAST CANCER PATIENTS

The analysis of the changes of the content of the angiogenic factor VEGFR-2 in the cytosol of the tumor and blood sera of the 30 breast can- cer patients determined by immunoenzyme method during neoadjuvant therapy is given. Likewise the correlation of this index with the main clinicomorphological c...

Full description

Bibliographic Details
Main Authors: E. A. Kim, A. M. Platova, I. V. Visotzkaya, E. S. Gershteyn, V. P. Letyagin, N. E. Kushlinskiy, E. E. Mironova
Format: Article
Language:Russian
Published: ABV-press 2014-09-01
Series:Опухоли женской репродуктивной системы
Online Access:https://ojrs.abvpress.ru/ojrs/article/view/334